Lecturers

Senu Apewokin, Ph.D.  University of Cinncinatti   Microbiome Science: Asking bedside questions at the bench

Senu Apewokin, Ph.D.
University of Cinncinatti

Microbiome Science: Asking bedside questions at the bench




Laura Conforti, Ph.D.  University of Cincinnati   Targeting ion channels to overcome the immunosuppressive tumor microenvironment

Laura Conforti, Ph.D.
University of Cincinnati

Targeting ion channels to overcome the immunosuppressive tumor microenvironment

Michael Hust, Ph.D.  Technische Universität Braunschweig   Fighting Pathogens and Toxins with human and human-like recombinant Antibodies

Michael Hust, Ph.D.
Technische Universität Braunschweig

Fighting Pathogens and Toxins with human and human-like recombinant Antibodies

David Boothman, Ph.D.   Indiana University School of Medicine   Exploiting the NQO1 bioactivatable ‘kiss of death’ for lung and pancreatic cancer therapies

David Boothman, Ph.D.
Indiana University School of Medicine

Exploiting the NQO1 bioactivatable ‘kiss of death’ for lung and pancreatic cancer therapies

Andrew Deng, Ph.D.  Bristol-Myers Squibb   Utilizing cytokines in immuno-therapy

Andrew Deng, Ph.D.
Bristol-Myers Squibb

Utilizing cytokines in immuno-therapy


Randolph J Noelle, Ph.D.  Geisel School of Medicine at Dartmouth  VISTA: a novel checkpoint regulator of innate and adaptive immunity

Randolph J Noelle, Ph.D.
Geisel School of Medicine at Dartmouth

VISTA: a novel checkpoint regulator of innate and adaptive immunity

Thomas Blankenstein, Ph.D.   Max Delbrück Center for Molecular Medicine   T cell receptor gene therapy

Thomas Blankenstein, Ph.D.
Max Delbrück Center for Molecular Medicine

T cell receptor gene therapy



Gerard Evan, Ph.D.  Caimbridge University

Gerard Evan, Ph.D.
Caimbridge University



Nicholas Restifo, Ph.D.  National Institutes of Health, USA

Nicholas Restifo, Ph.D.
National Institutes of Health, USA


Alex Bullock, Ph.D.  University of Oxford   Affordable drug development for paediatric brain tumors

Alex Bullock, Ph.D.
University of Oxford

Affordable drug development for paediatric brain tumors



Naama Geva-Zatorsky, Ph.D.   Technion Integrated Cancer Center

Naama Geva-Zatorsky, Ph.D.
Technion Integrated Cancer Center


Caetano Reis e Sousa, Ph.D.  The Francis Crick Institute   Dendritic cells in immunity to cancer

Caetano Reis e Sousa, Ph.D.
The Francis Crick Institute

Dendritic cells in immunity to cancer


Laurence Zitvogel, Ph.D.  German Cancer Research Center

Laurence Zitvogel, Ph.D.
German Cancer Research Center

Thorbald van Hall, Ph.D.  Leiden University Medical Center   NKG2A as a novel checkpoint for cancer immunotherapy

Thorbald van Hall, Ph.D. Leiden University Medical Center

NKG2A as a novel checkpoint for cancer immunotherapy

Jonathon Swann, Ph.D.  Imperial College   Gut microbiota and their biochemical communication with the host

Jonathon Swann, Ph.D.
Imperial College

Gut microbiota and their biochemical communication with the host

Ravid Straussman, Ph.D.   The Weizmann Institute

Ravid Straussman, Ph.D.
The Weizmann Institute

Thomas Thompson, Ph.D.   University of Cinncinatti   Therapeutic modulation of the TGFß Superfamily

Thomas Thompson, Ph.D.
University of Cinncinatti

Therapeutic modulation of the TGFß Superfamily

Organizing Committee:

Farzin Farzaneh
Peter Stambrook

Executive Committee: 
James Kang
Thomas Thompson
Warren Zimmer

FULL PROGRAM